The second prescription in homeopathic case management

The second prescription is the decision a practitioner faces at the first follow-up, after the simillimum has been given once and the case is reviewed. It is the point at which most case-management error concentrates: the remedy that acted may need repeating, waiting on, changing, or antidoting, and the choice between these four moves is the harder skill, well above the first prescription. Hahnemann devotes a long run of aphorisms in the sixth edition of the Organon to exactly this judgement, and Kent's Lectures on Homoeopathic Philosophy organises a substantial portion of the case-management teaching around it.

What the second prescription decides

The second prescription is a fork. After the first remedy, the practitioner reviews the follow-up and chooses one of four moves: repeat the same remedy at the same or a different potency, wait without prescribing while the original dose continues to act, change to a different remedy, or address an interfering factor that has stalled the case. Hahnemann's central instruction in §246–§248 of the sixth edition is restraint: a remedy that is acting must not be interrupted, and a dose is repeated only when improvement has clearly stalled and the same symptom-picture remains. The most common error is the premature change of remedy while the first remedy is still acting.

The four moves, compared

Reading the first follow-up

Kent frames the first follow-up as a set of possible observations each pointing to a different second prescription, and the framework is still taught in this form. The practical core reduces to a few patterns.

A long, gentle amelioration of the whole person calls for waiting. A short, sharp amelioration followed by relapse means the potency was too low or the dose needs repeating. A return of old symptoms in reverse order of their appearance, following Hering's law, is a favourable sign that the remedy has acted, and again calls for waiting rather than re-prescribing. A new symptom-picture that no longer matches the first remedy calls for re-taking the case and re-repertorising the totality. No reaction at all points away from the remedy and toward an interfering factor — a maintaining cause, an antidoting habit, or an incorrect first prescription.

A sudden severe aggravation of a chronic complaint, an abrupt suppression of a discharge with new internal symptoms, or the emergence of neurological signs after a prescription are red-flag presentations that need prompt clinical assessment alongside the case review.

Potency on the second prescription

The second prescription is where potency strategy becomes concrete. The two dominant traditions diverge.

The single-dose-and-wait school, associated with Kent and much of twentieth-century classical practice, re-doses at a higher centesimal step (200C after 30C, 1M after 200C) only once the prior potency has exhausted its action.

The LM or Q-potency school, set out by Hahnemann in the sixth-edition aphorisms, repeats a low ascending LM potency at short intervals, succussing the bottle before each dose so that no two doses are identical. The LM vs centesimal and potency selection pages cover the trade-offs in detail. The second prescription is the first place those trade-offs are tested against a real follow-up.

Keeping the case legible across visits

The second-prescription decision is made against the case history, not against software. What software does is keep that history legible: symptoms grouped by onset date and anatomical zone — the structure a reverse-order-of-appearance reading depends on — and side-by-side comparison of the initial repertorisation with the follow-up. That turns the decision from a memory exercise into a documented comparison between two analyses, which is what makes the difference between repeat, change, and wait visible at all.

Practitioners working without that structure can build it on paper; those who want a digital case timeline and rubric-sheet import between visits can search the free repertory by symptom and keep the same analysis open across follow-ups.

References

Hahnemann, S. (1842) Organon of the Medical Art, sixth edition, edited and translated by W. B. O'Reilly (1996), Palo Alto: Birdcage Books — aphorisms §245–§252 on repetition of the dose, and §270 with the §246 footnote on the preparation and repetition of the LM (Q) potencies.

Kent, J. T. (1900) Lectures on Homoeopathic Philosophy, Lancaster: Examiner Printing House, Lectures XXXIII–XXXV on the observations after the remedy and the second prescription, https://archive.org/details/lecturesonhomoeo00kent.

Close, S. (1924) The Genius of Homoeopathy: Lectures and Essays on Homoeopathic Philosophy, Philadelphia: Boericke & Tafel, chapters on the second prescription and the management of the case, https://archive.org/details/geniusofhomoeopa00clos.

Vithoulkas, G. (1980) The Science of Homeopathy, New York: Grove Press, chapters 14–16 on follow-up and the evaluation of the response.